We are monitoring the impact of COVID-19 & Recession alarm on MEA Injectable Drug Delivery Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Injectable Drug Delivery Market Research Report – Segmented By Device Type, Formulation, Therapeutic Use, End User, & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2021
Pages: 145

MEA Injectable Drug Delivery Market Size (2022 to 2027)

The size of the Middle East and Africa Injectable Drug Delivery Market was valued at USD 4023.77 Million in 2022. It is further estimated to be growing at a CAGR of 11.93% and worth USD 7069.13 Million by 2027.

The Middle East and Africa market is majorly expected to be growing due to increased public awareness and a large population of chronic disease patients. The rise of chronic diseases, technological advancements in pharmaceutical technology, high funds for research and development, and the growth of the medical industry. The growing incidence of AIDS, diabetes, Alzheimer's disease, cancer, and arthritis has led to new drug delivery methods. This has increased the demand for advanced medical products.

With the success of the health awareness programs against HIV and tuberculosis, the death rate is decreasing in South Africa, and life expectancy is increasing. According to the World Health Organization, there is an increase in cancer patients in the country. The MEA region has seen a steady rise in the population, especially people over age 60 and above. The increase in the geriatric population and the increasing prevalence of cardiovascular diseases are driving the market growth in these countries.

Advanced technologies, preference of individual therapy, and controlled drug release by injectable drug delivery are growing the product's popularity. Due to the rapidly changing market for the use of injectable drug delivery technology, medical device companies that can launch new innovative equipment to expand their product portfolios will gather enormous benefits. In 2018, Israeli scientists developed cutting-edge drug delivery technology used with long-wave light to deliver drugs.

However, factors such as fear of injury and risk of infection, high development costs, poor reimbursement plans, and a strict regulatory framework are the main challenges faced by the MEA injectable drug delivery market over the forecast period.

This research report on the Middle East and Africa injectable drug delivery market has been segmented and sub-segmented into the following categories:

By Device Type: 

  • Self-Injection Devices
  • Conventional Devices

By Formulation: 

  • Conventional Drug Delivery
  • Novel Drug Delivery

By Therapeutic use: 

  • Autoimmune Disorders
  • Hormonal Disorders
  • Oncology

By End User: 

  • Hospitals
  • Homecare Settings
  • Research Institutes
  • Clinical Laboratories

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Middle East region is estimated to dominate the studied market, attributing to the increased elderly population more prone to chronic diseases. In turkey, a senior population of 7.25 million in 2018 is a jump of around 16.55% from approximately 6.28 million in 2014. In addition, according to NCBI, an estimated 3.48 million adults living in Turkey were reported to be affected by some form of cardiovascular disease in 2016.

According to an article published in 2018, Saudi Arabia's senior population aged 60 and over will reach 25.6% of the country's total population by 2050. While, the number of people aged 80 and above is predicted to reach 1.68 million, or 4.56% of the total population. In Saudi Arabia, this increase in the elderly population results in higher healthcare spending, which will lead to significant market growth in the coming years.

Regions in MEA such as Qatar, South Africa, Oman, and United Arab Emirates have seen an increasing prevalence of cardiovascular disease, which has become a cause of significant public health concern leading to nearly 46.8% of the total death rate. As a result, public healthcare officials focus on growing awareness and free camps for early detection for a better prognosis, leading to a better quality of life. These factors are driving the growth of the market during the projected period.

KEY MARKET PLAYERS:

Companies playing an influential role in the Middle East & Africa injectable drug delivery market profiled in this report are Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation, and West Pharmaceutical Inc.

1.Introduction              

                1.1 Market Definition

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods      

                1.4 General Study Assumptions  

2. Research Methodology                       

                2.1 Introduction           

                2.2 Research Phases  

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design     

                2.4 Study Timeline      

3. Overview                   

                3.1 Executive Summary  

                3.2 Key Inferences     

                3.3 Epidemology          

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                

                4.1 Market Drivers      

                4.2 Market Restraints

                4.3 Key Challenges     

                4.4 Current Opportunities in the Market          

5. Market Segmentation                          

                5.1 Device Type           

                                5.1.1 Introduction                                           

                                5.1.2 Self-injection Devices                                         

                                5.1.3  Conventional Devices                                        

                                5.1.4  Y-o-Y Growth Analysis, By Device Type                                      

                                5.1.5  Market Attractiveness Analysis, By Device Type                                    

                                5.1.6  Market Share Analysis, By Device Type                                     

                5.2 Formulation           

                                5.2.1 Introduction                                           

                                5.2.2 Conventional Drug Delivery                                             

                                5.2.3  Novel Drug Delivery                                           

                                5.2.4 Y-o-Y Growth Analysis, By Formulation                                       

                                5.2.5 Market Attractiveness Analysis, By Formulation                                     

                                5.2.6 Market Share Analysis, By Formulation                                      

                5.3 Therapeutic Use   

                                5.3.1 Introduction                                           

                                5.3.2 Autoimmune Disorders                                     

                                5.3.3 Hormonal Disorders                                            

                                5.3.4 Oncology                                 

                                5.3.5 Y-o-Y Growth Analysis, By Therapeutic Use

                                5.3.6  Market Attractiveness Analysis, By Therapeutic Use                                           

                                5.3.7  Market Share Analysis, By Therapeutic Use                                             

                5.4 End-user

                                5.4.1 Introduction                                           

                                5.4.2 Hospitals                                  

                                5.4.3 Homecare Settings

                                5.4.4 Research Institutes                                             

                                5.4.5 Clinical Laboratories                                            

                                5.4.6 Other                                        

                                5.4.7 Y-o-Y Growth Analysis, By End-user

                                5.4.8  Market Attractiveness Analysis, By End-user

                                5.4.9  Market Share Analysis, By End-user

6. Geographical Analysis                          

                6.1 Introduction           

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

  6.1.3.1 By Geographical Area                     

  6.1.3.2 By Device Type                  

  6.1.3.3 By Formulation                  

  6.1.3.4 By Therapeutic Use                         

  6.1.3.5 By End-user

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Device Type                  

  6.1.4.3 By Formulation                  

  6.1.4.4 By Therapeutic Use                         

  6.1.4.5 By End-user

                                6.1.5  Market Share Analysis                                      

  6.1.5.1 By Geographical Area                     

  6.1.5.2 By Device Type                  

  6.1.5.3 By Formulation                  

  6.1.5.4 By Therapeutic Use                         

  6.1.5.5 By End-user

                6.2 Middle-East            

                6.3 Africa        

7.Strategic Analysis                    

                7.1 PESTLE analysis     

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis          

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                     

                8.1 Alkermes Inc.        

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Bend Research      

                8.3 BIND Biosciences Inc.         

                8.4 Endocyte 

                8.5 Genentech Inc.     

                8.6 MicroCHIPS Inc.    

                8.7 Pearl Therapeutics Inc.      

                8.8 Polymer Factory   

                8.9 Presage Bioscience   

                8.10  QLT Inc. 

                8.11 UCB Group.          

9.Competitive Landscape                        

                9.1 Market share analysis        

                9.2 Merger and Acquisition Analysis   

                9.3 Agreements, collaborations and Joint Ventures     

                9.4 New Product Launches     

10.Market Outlook and Investment Opportunities                      

Appendix                       

                a) List of Tables  

                b) List of Figures          

  1. Middle East & Africa Injectable Drug Delivery Market, By Device Type , From 2022 - 2027 (USD Million)
  2. Middle East & Africa Self-injection Devices Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Conventional Devices Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Injectable Drug Delivery Market, By Formulation, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Conventional Drug Delivery Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Novel Drug Delivery Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Injectable Drug Delivery Market, By Therapeutic Use, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Autoimmune Disorders Market, By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Hormonal Disorders Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Oncology Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Injectable Drug Delivery Market, By End-user, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Homecare Settings Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Research Institutes Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Clinical Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  16. Middle East Injectable Drug Delivery Market, By Device Type , From 2022 - 2027 (USD Million)
  17. Middle East Injectable Drug Delivery Market, By Formulation, From 2022 - 2027 (USD Million)
  18. Middle East Injectable Drug Delivery Market, By Therapeutic Use, From 2022 - 2027 (USD Million)
  19. Middle East Injectable Drug Delivery Market, By End-user, From 2022 - 2027 (USD Million)
  20. Africa Injectable Drug Delivery Market, By Device Type , From 2022 - 2027 (USD Million)
  21. Africa Injectable Drug Delivery Market, By Formulation, From 2022 - 2027 (USD Million)
  22. Africa Injectable Drug Delivery Market, By Therapeutic Use, From 2022 - 2027 (USD Million)
  23. Africa Injectable Drug Delivery Market, By End-user, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample